Analystreport

Achieve Life Sciences, Inc. (NASDAQ: ACHV) had its price target raised by analysts at Oppenheimer Holdings Inc. from $23.00 to $27.00.

Achieve Life Sciences, Inc. - Common Shares  (ACHV) 
Last achieve life sciences, inc. - common shares earnings: 3/13 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.achievelifesciences.com